risk adaptive management for high risk multiple myeloma - blood cancer onctalk
Published 1 year ago • 16 plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
3:53
identifying smoldering multiple myeloma patients: risk factors - blood cancer onctalk 2023
-
6:16
treatment options for multiple myeloma - blood cancer onctalk
-
4:20
the spectrum of disease in multiple myeloma - blood cancer onctalk
-
4:15
treatment timing for multiple myeloma - blood cancer onctalk
-
3:41
cellular therapies in multiple myeloma - blood cancer onctalk
-
6:45
approaches for treatment of multiple myeloma - blood cancer onctalk
-
2:25
maintenance treatment in multiple myeloma - blood cancer onctalk
-
6:06
immunotherapy in multiple myeloma: an overview - blood cancer onctalk 2023
-
2:44
the future of multiple myeloma treatment - blood cancer onctalk
-
3:24
clinical trials in patients with high risk or smm - blood cancer onctalk 2023
-
2:43
curative strategies for patients with smoldering multiple myeloma - blood cancer onctalk 2023
-
2:44
approaching treatment for smoldering multiple myeloma - blood cancer onctalk 2023
-
2:12
phase ii clinical trials for intermediate to high risk smm - blood cancer onctalk 2023
-
3:07
treating relapsed multiple myeloma - blood cancer onctalk
-
4:10
what is smoldering multiple myeloma? - blood cancer onctalk 2023
-
1:58
multiple myeloma and type 2 diabetes: first steps - blood cancer onctalk
-
8:06
advances in multiple myeloma: what is needed to get to a cure? - blood cancer onctalk